John Hohneker - 16 May 2024 Form 4 Insider Report for ArriVent BioPharma, Inc. (AVBP)

Role
Director
Signature
/s/ James Kastenmayer, Attorney-in-Fact for John Hohneker
Issuer symbol
AVBP
Transactions as of
16 May 2024
Net transactions value
$0
Form type
4
Filing time
20 May 2024, 17:30:56 UTC
Previous filing
01 Apr 2024
Next filing
23 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVBP Stock Option (right to buy) Award $0 +29,550 $0.000000 29,550 16 May 2024 Common Stock 29,550 $20.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest annually in equal installments over three years, subject to the Reporting Person's continued service through the applicable vesting date.